TAYLOR SELKE: Open Payments
NPI 1033822119 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 8 companies in 2025. Trend: 2023 $508 · 2024 $235 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $35 |
| ABBVIE INC. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: Qelbree, ZEPBOUND, VRAYLAR, INGREZZA, ZURZUVAE, Jornay PM, SPRAVATO, FANAPT.
Industry payments across RI — which companies pay providers there.
